tadalafil dosage - viagra - augmentin uses - http://sildenafilgeneric-citrate.com/ - levitra 20mg vs viagra 100mg - furosemide for dogs - lisinopril hctz - cialis generic - gabapentin 300mg - doxycycline hyclate 100mg

Latest News

LifeApps Digital Media, Inc. is on the Right Side of Growing Trend

LifeApps Digital Media, Inc. is on the Right Side of Growing Trend

Written by ι Stock Market Media — April 5, 2013

Just when you think you’ve gotten a handle on things, a new technology comes along and completely turns your world upside down.  LifeApps Digital Media, Inc. (OTCQB: LFAP), a digital media company focused on health, fitness, sports publications, and next-generation social networks, is on the right side of this particular change. 

Move over websites and hello “Apps,” I mean c’mon everyone is doing it.  Whether you’re an Apple baby ...

Read More →
0

Celgene, Corp., Nuvilex, Inc. on Similar Path in Fight Against Pancreatic Cancer

Celgene, Corp., Nuvilex, Inc. on Similar Path in Fight Against Pancreatic Cancer

Written by ι Stock Market Media — March 5, 2013

In late January, those with advanced stage pancreatic cancer received some good news when Celgene, Corp (NASDAQ: CELG) announced the results of its large scale phase III trial at the 2013 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO), held in San Francisco. 

Pancreatic cancer is difficult to diagnose and treat until it is at an advanced stage.  Survival of patients with advanced, inoperable pancreatic cancer ...

Read More →
0

INSCOR, Inc. A Penny Stocks Funding Solution to America’s Trillion Dollar Problem

INSCOR, Inc. A Penny Stocks Funding Solution to America’s Trillion Dollar Problem

Written by ι Stock Market Media — April 4, 2013

Changes in recent accounting rules have left municipalities, universities, hospitals and other government entities highly exposed and dramatically under-funded.  INSCOR, Inc. (OTC Pink: IOGA) seems to have a solution for part of what some are conservatively estimating is $1.5-trillion in unfunded liabilities.

Without getting too bogged down in the minutia that is accounting rules, employee retirement benefit plans and insurance policies – let’s just say the solution that Read More →

0

Nuvilex, Inc. Pancreatic Cancer Therapy Offers Higher Survival Rate and Less Toxicity than Competitors

Nuvilex, Inc. Pancreatic Cancer Therapy Offers Higher Survival Rate and Less Toxicity than Competitors

Written by ι Stock Market Media Group Staff — May 2, 2013

Nuvilex, Inc. (OTCQB: NVLX) has already produced impressive results from its two independent Phase II clinical trials in patients with advanced, inoperable pancreatic cancer.  Two key results pulled from the data of those trials, are that the median survival rate was higher than that of the current gold standard for the disease and better than those of other competitors’ treatments when clinical trial reports are examined.  Furthermore, the overall side-effect profile ...

Read More →
0

Nuvilex, Inc. Phase III Clinical Trials in Strong Hands with Dr. Gerald Crabtree

Nuvilex, Inc. Phase III Clinical Trials in Strong Hands with Dr. Gerald Crabtree

Written by ι Stock Market Media — April 1, 2013

Nuvilex, Inc. (OTCQB: NVLX) CEO, Dr. Robert Ryan knew exactly what he was doing 2 years ago when he announced Dr. Gerald Crabtree would be joining his team as the company’s Chief Operating Officer (COO).  He is the right guy, at the right place, at the right time, and Dr. Ryan is expecting his COO’s extensive expertise to help carry this small biotech across the finish line.

Dr. Gerald Crabtree ...

Read More →
0

Nuvilex, Inc. ι Finding the Green is in the Science

Nuvilex, Inc. ι Finding the Green is in the Science

Written by ι Stock Market Media — February 21, 2013

When Colorado and Washington passed legislation making marijuana legal for recreational use in the November elections, the rush was on – the Green Rush that is. All told, 18 states voted to legalize marijuana for medicinal purposes, and two elected to legalize it altogether. Before the elections, companies that are in the medical marijuana industry, saw a slow rise in price per share, and then as investors figured out the huge upside ...

Read More →
0
Page 31 of 32 «...10202829303132
ContactUs.com ContactUs.com